take mysteri whether lh saw similar trend solv
manag cut fy forecast quest focus primarili ar accrual lh shortfal
appear primarili volum base dtc genom horizon lower referr volum weather respect
total shock saw volum shift prior chang ahead updat
dtc genom comment bit curiou could season bias may shift
sampl process furthermor lh alreadi underway restructur step given pend volum
headwind like upsized/acceler unfortun unlik materi chang
trajectori lsd ep growth similar disappoint outcom howev encourag
see covanc relat issu note updat diversif cro complex
question time past year certainli help case provid avenu potenti
offset particularli front expect share today surpris element
cut remov
announc morn labcorp updat ep guidanc
revenu guidanc lower guidanc stem lower-than-
expect volum diagnost slower direct-to-consum genet test lower referr hospit health
system volum declin certain soon-to-be-nonexclus manag care plan weather compani
also note previously-announc cost reduct plan would enough off-set declin manag
reiter confid covanc outlook look lh expect modest y-o-i ep growth
provid formal guidanc ep call februari
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
valuat methodolog base mix discount cash flow analysi rel valuat multipl
downsid risk potenti pama relat price cut bleed commerci price ultim lead
neg margin cycl recent vertic integr hc servic organ lead increas price pressur given
heighten focu unit cost challeng associ integr small outreach lab deal could depress return
invest capit prove distract effort off-set pama cut increas cost save could yield servic challeng
ultim depress core organ volum poor perform major clinic trial could harm cvd reput lead
signific shift cro relat market share signific down-tick biotech relat fund could lead materi
growth downshift earli phase demand harm profit
articl articl
time dissemin novemb
analyst elizabeth anderson suzi yoon ross muken primarili respons prepar research report attest
follow view opinion render research report reflect person view subject compani
issuer part research analyst compens directli relat specif recommend view
research report
report approv and/or distribut evercor group llc evercor group licens broker-deal regul
industri regulatori author finra intern strategi invest group uk limit lsi uk authoris
regul unit kingdom financi conduct author institut sale trade research busi evercor group
lsi uk collect oper global market brand name evercor lsi evercor lsi evercor group lsi uk
subsidiari evercor partner inc evercor partner trademark logo servic mark shown report regist
trademark evercor partner
analyst associ respons prepar report receiv compens base variou factor includ evercor partner
total revenu portion gener affili invest bank transact evercor lsi seek updat research
appropri variou regul may prevent happen certain instanc asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgment
evercor lsi gener prohibit analyst associ member household maintain financi interest secur
compani analyst area coverag except polici requir specif approv member complianc
depart ownership subject complianc applic regul disclosur evercor lsi also prohibit analyst associ
member household serv offic director advisori board member employe compani analyst
report may includ tactic call describ near-term event catalyst affect subject compani market overal
expect short-term price impact equiti share subject compani tactic call separ analyst
long-term recommend outperform under-perform reflect stock forward expect return formal rate
may differ target price recommend reflect analyst long-term view
applic current disclosur regard subject compani cover report avail offic evercor lsi
obtain write evercor group llc attn complianc fifth avenu floor new york ny
evercor partner affili respect director offic member employe may interest
qualifi hold issuer mention report evercor partner affili may busi relationship
compani mention report
addit inform secur financi instrument mention report avail upon request
evercor lsi recommend base stock total forecast return next month total forecast return equal
expect percentag price return plu gross dividend yield divid stock coverag three primari rate categori
outperform- total forecast return expect greater expect total return analyst coverag univers
line- total forecast return expect line expect total return analyst univers
underperform- total forecast return expect less expect total return analyst univers
coverag suspended- rate target price remov pursuant evercor lsi polici evercor act advisori
capac merger strateg transact involv compani certain circumst
rate suspended- evercor lsi suspend rate target price stock suffici fundament basi
determin legal regulatori polici constraint around publish rate target price previou rate target price
longer effect compani reli upon
prior octob coverag suspend rate suspend categori includ categori suspend
flnra requir member use rate system term buy hold/neutr sell equat
rate categori purpos evercor lsi rate distribut outperform
under-perform rate equat buy hold sell respect
prior march evercor lsi recommend base stock total forecast return next month
buy- total forecast return expect greater
hold- total forecast return expect greater equal less equal
sell -the total forecast return expect less
octob evercor partner acquir intern strategi invest group llc lsi group lsi uk acquisit
transfer evercor group research sale trade busi lsi group decemb combin research sale
trade busi transfer back evercor group intern reorgan sinc acquisit combin research sale
trade busi oper global market brand name evercor lsi
lsi group lsi uk
prior octob rate system lsi group llc lsi uk base risk adjust total return
buy- return
neutral return
cautious- return
disclosur purpos lsi group lsi uk rate view follow strong buy buy equat buy neutral equat hold
